The Early Stage Venture Capital Limited Partnership (ESVCLP) regime was introduced in Australia in 2007 as a vehicle to stimulate investment in early-stage companies. It provides generous tax concessions to both investors and fund managers, making it an attractive structure for Australian focused venture capital funds. Under this regime, investors in an ESVCLP are generally exempt from Australian income tax on all or part of the returns (income and capital gains) from eligible venture capital investments (EVCI) and are entitled to a nonrefundable tax offset of up to 10% of their invested amount. Fund managers, meanwhile, benefit from having their performance-based carried interest deemed to be on capital account which can significantly reduce tax on their reward for having invested well.
This paper provides a technical overview of the ESVCLP framework. We begin with the historical background of limited partnership taxation in Australia and the policy intent behind the venture capital incentives. We then outline the key structural elements of an ESVCLP fund, the general partner, limited partners, and the fund vehicle, and the specific tax concessions available (including flow-through treatment, investor exemptions, and carried interest rules). Finally, we discuss practical issues that have emerged in the operation of ESVCLPs and review current capital deployment trends in the ESVCLP sector, including how the ESVCLP program has built a significant pool of capital pending investment into early-stage companies, which may positively impact future M&A activity in Australia.
Read the Full Paper
Code of Practice 9 – What Is It and Is It Right for You?
December 12, 2025
At A&M, we regularly work alongside our clients’ existing advisors to ensure that they benefit from our extensive experience in managing Code of Practice 9 enquiries.
A&M Benefits Reference Guide
December 11, 2025
Many of the limits that pertain to qualified retirement plans and benefit plans are set by the Internal Revenue Service (IRS) and are subject to cost-of-living adjustments. In 2026, employees will be able to increase their retirement savings and contributions to health savings accounts as a result of the increased limits. The IRS limits for 2026 are summarized in the table below along with certain important compliance deadlines.
Pharma in Focus: A Prescription for Thai Tax & Tariff Health
December 8, 2025
Alvarez & Marsal recently hosted an engaging and practical session tailored for tax, finance, and trade professionals in the pharmaceutical industry. This first edition of our Thailand Tax Talk: Industry Series explored how tax leaders in the pharma sector can respond to increasing regulatory pressure, operational complexity, and cross-border trade disruption.
Supreme Court Upholds Delhi High Court Ruling: Indian Subsidiary Does Not Automatically Constitute PE, and No Further Profit Attribution Is Warranted Once the Subsidiary Arm’s Length Remuneration Is Paid
December 5, 2025
The Supreme Court’s affirmation of the Delhi High Court ruling in the Progress Rail case provides important clarity on Permanent Establishment standards in India.
The decision reinforces key principles on control, core functions, agency thresholds, and profit attribution.
It further underscores that arm’s-length remuneration to Indian subsidiaries precludes additional attribution.
A significant development for multinational enterprises evaluating their India-linked operating models.